NeurogesX, Inc. Community Page | What other sites are saying about NeurogesX, Inc.

NeurogesX, Inc.

(OP: NGSX)

0.0103 USD -0.0036 (-25.90%)

Streaming Delayed Price / Updated: 9:30 AM EDT, Jun 19, 2013 / Add to My Watchlist

(NGSX) Community Analysis from

READ MORE (NGSX)

Bulls REASONS TO BUY

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

June 19, 2013

NeurogesX Reports Third Quarter Loss of $.72 per Share

(Benzinga, 11/3/10)

NeurogesX, Inc. (Nasdaq: NGSX) today reported results for its third quarter ended September 30, 2010. Total revenue for the three months ended September 30, 2010 was $2.1 million which consisted of $1.9 million in collaboration...(read more)

I never sleep. Got to hand you these tips.

(Penny Stock DD, 12/25/09)

Possible take over canidates and really do your dd. I cannot offer investment advice. I can only offer Tips. My work day never stops for the benefit of members. NeurogesX Inc...(read more)

(NGSX) NeurogesX – Bull of the Day

(Stock Blog Hub, 11/18/09)

NeurogesX (NGSX) received some very good news this week when the U.S. FDA approved Qutenza for the management of postherpetic neuralgia (PHN). Management will now move forward with preparing for the...(read more)

View all posts about NeurogesX (NGSX)

NeurogesX (NGSX) Company Overview

There is no analysis for NGSX yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates